WellCare started at buy by Argus

WellCare initiated with a Buy at Argus. Argus analyst John Staszak initiated WellCare with a Buy rating and $265 price target, telling investors in a research note that WellCare is well positioned to benefit from continued strong growth in the Medicaid, Medicare Advantage and Medicare Part D markets, as well as from geographic expansion and acquisitions. In a research note to investors, Staszak contended that WellCare may also be an attractive acquisition target for a larger insurer.

https://bit.ly/2xSQvwQ